enow.com Web Search

  1. Ads

    related to: latest therapies for essential tremor

Search results

  1. Results from the WOW.Com Content Network
  2. Ulixacaltamide - Wikipedia

    en.wikipedia.org/wiki/Ulixacaltamide

    Ulixacaltamide is an investigational new drug developed by Praxis Precision Medicines, designed to treat essential tremor, [1] a common neurological disorder characterized by involuntary rhythmic shaking. It functions as a selective inhibitor of T-type calcium channels, which are implicated in the abnormal neuronal activity associated with ...

  3. PRAX-114 - Wikipedia

    en.wikipedia.org/wiki/PRAX-114

    As of March 2023, PRAX-114 is in phase 2/3 clinical trials for major depressive disorder and phase 2 clinical trials for essential tremor. [2] [3] [1] No recent development has been reported for treatment of depressive disorders and epilepsy. [2]

  4. Essential tremor - Wikipedia

    en.wikipedia.org/wiki/Essential_tremor

    Essential tremor (ET), also called benign tremor, familial tremor, and idiopathic tremor, is a medical condition characterized by involuntary rhythmic contractions and relaxations (oscillations or twitching movements) of certain muscle groups in one or more body parts of unknown cause. [6]

  5. Jazz Pharmaceuticals' tremor drug fails in mid-stage study - AOL

    www.aol.com/news/jazz-pharmaceuticals-tremor...

    (Reuters) -Jazz Pharmaceuticals said on Thursday its experimental drug to treat a common movement disorder failed to reduce tremor severity in a mid-stage study, sending the company's shares down ...

  6. Adaptive Deep Brain Stimulation - Wikipedia

    en.wikipedia.org/wiki/Adaptive_Deep_Brain...

    Essential tremor (ET) [ edit ] Adaptive deep brain stimulation (aDBS) may be an effective tool in the treatment of essential tremor (ET), which is one of the most common neurological movement disorders. aDBS for ET is however more focused on a closed-loop technology based on external sensors.

  7. Deep brain stimulation - Wikipedia

    en.wikipedia.org/wiki/Deep_brain_stimulation

    DBS has been approved by the Food and Drug Administration as a treatment for essential and Parkinsonian tremor and since 1997, [3] and for Parkinson's disease (PD) since 2002. DBS was approved as humanitarian device exemptions for dystonia in 2003, [4] obsessive–compulsive disorder (OCD) in 2009, and approved for epilepsy in 2018.

  1. Ads

    related to: latest therapies for essential tremor